ALTH (Allos Therapeutic)
All Pro Portfolios with ALTH
All Do-It-Yourself Portfolios with ALTH
- Total Do-It-Yourself Portfolios with ALTH:
- Ing RJ
- James Thomas Smith Portfolio 1
- Darius Reid Portfolio 1
- pathan786 Portfolio 1
- tn trader 1
- galatica
- PharmSpring
- watchlist-current
- rpasquale Portfolio 1
- Kavi
- richerickson Portfolio 1
- Michal Barnes Portfolio 1
- rguiney Portfolio 1
- Barron's Research Reports 11-10-2007
- irvgruve Portfolio 1
- PART 9 JPMorgan 26th Annual Healthcare Conf 1/10/08..4th Day Reporting Companies..Nymph Take
- Cramer's Take on Headline Stocks 4-13-09
- ASCO 2009 Nymph's Watch List.
- Top George Soros Short Squeeze Plays
- Rocket Stocks for the Week of Sept. 7 - Sept. 11
- gnoble - Speculative stocks.
- Cramer's Cancer-Fighting Stocks Portfolio
- show more
- 44
- Raymond Tsai Portfolio 1
- walt roth Portfolio 1
- bardhan Portfolio 1
- rmartin Portfolio 1
- tedhart1976 Portfolio 1
- corky016 Portfolio 1
- Outperform
- davincicode Portfolio 1
- fab401K
- Pablo
- investhorr
- pathan_786 Portfolio 1
- BENITRANS HT-SFM-X
- Little Jo
- uncle jack
- Rocket Stocks for the week of March 2nd – March 6th
- Fast Money's Cancer Trades
- brataatmadja
- ninja trader
- Watch List - Healthcare Plays
- maybe will work?
- Cramer's Cancer Takeover Targets
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:barrons3 |
Date:11 19 09 |
Cramer named Exelsis (EXEL), Allos Therapeutics (ALTH) and Immunogen (IMGN) as potential targets for Bristol, all of which "would increase its cancer franchise." |
|
Not yet rated
Rate now:
|
|
By:RhinoStocks |
Date:09 07 09 |
A new FDA recommendation for Allos Theraputics' drug Folotyn could spur this stock on in the coming week. |
|
Not yet rated
Rate now:
|
|
Date:07 27 09 |
|
9.1 |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:05 13 09 |
That could move a slew of players including OSI Pharmaceuticals (OSIP), Cougar Biotech (CGRB) , Medarex (MEDX), Exelixis (EXEL), and Allos (ALTH). |
|
Not yet rated
Rate now:
|
|
Date:04 13 09 |
|
"They killed the momentum with the secondary offering, but it's still a good speculation. I still like the story." ("Mad Money Lightning Round," 4-9-09) |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:11 10 07 |
Strong Buy - Price 5.63 on Nov. 6 |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Upgraded by RBC Capital Mkts from Sector Perform to Outperform |
|
Not yet rated
Rate now:
|
|
By:baba |
Date:02 06 07 |
Nice pipeline also Baker Brothers bought a ton of this stock |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |
